We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Novel ALS Therapy in Human Clinical Trials

News   Jul 17, 2018 | Original Story by Tamara Bhandari for WUSTL

 
Novel ALS Therapy in Human Clinical Trials

Robert Bucelli, MD, PhD, measures Gregory Easter's neuromuscular function. Easter, who has an inherited form of amytrophic lateral sclerosis, a fatal neuromuscular disease, is taking part in a clinical trial to evaluate an experimental drug. New research at Washington University School of Medicine in St. Louis shows the drug extends survival and reverses some neuromuscular damage in mice and rats and may help people whose disease is caused by mutations in the gene SOD1. Credit: Mike Worful, WUSTL.

 
 
Advertisement
 

RELATED ARTICLES

Walking in "Blue Spaces" Can Benefit Mental Health

News

A new study has identified benefits to mood and well-being associated with short, frequent walks near bodies of water.

READ MORE

MRI Imaging of COVID-19 Patients Offers Hope for Recovery

News

A case study led by investigators at Massachusetts General Hospital has indicated that unresponsive patients with COVID-19 may have a better chance of recovery than expected.

READ MORE

How Microglia Chomp Paths Through the Brain's Scaffolding To Promote Plasticity

News

A new study has explored the role that the brain's immune cells, microglia, have in helping synapses form. These cells chomp away at the matrix proteins blocking synapses' paths, making a space for neurons to find one another.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE